Stay updated on Solanezumab vs Placebo in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.

Latest updates to the Solanezumab vs Placebo in Alzheimer's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed; this appears to be a minor software update with no changes to study data, eligibility criteria, or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows Revision: v3.4.1 replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedUI updates include showing the glossary and capitalization tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a revision bump from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.3.4 updated from v3.3.3 on the page.SummaryDifference0.0%

- Check90 days agoChange DetectedThe study's site locations were updated: many new locations across the US, Australia, and Canada were added and several existing locations were removed.SummaryDifference2%

Stay in the know with updates to Solanezumab vs Placebo in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.